Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
IDEXX Laboratories, Inc. is a leading provider of veterinary diagnostics and software solutions, primarily serving the pet healthcare market. The company differentiates itself through its extensive product portfolio, including rapid diagnostic tests and advanced imaging systems, which are supported by a strong global distribution network across North America, Europe, and Asia.
IDEXX generates revenue primarily through the sale of diagnostic tests, instruments, and software solutions to veterinary practices. The company benefits from strong pricing power due to its innovative product offerings and established brand reputation, allowing it to maintain high gross margins.
Growth in pet ownership rates, particularly in North America and Europe
Expansion of diagnostic testing adoption in veterinary practices
Innovation and introduction of new diagnostic products
Global market penetration in emerging economies
Technological disruption from emerging diagnostic technologies
Regulatory changes affecting veterinary products and services
Increased competition from new entrants in the veterinary diagnostics space
Potential pricing pressure from competitors offering lower-cost alternatives
Moderate financial risk due to a debt-to-equity ratio of 0.71, which could impact financial flexibility in a downturn
Potential liquidity risks if cash flow generation does not meet expectations
moderate - IDEXX's business is somewhat insulated from economic downturns due to the essential nature of pet healthcare, but overall consumer spending can influence veterinary service demand.
Interest rates have a limited direct impact on IDEXX, but rising rates could affect consumer discretionary spending on pet healthcare services, potentially slowing growth.
minimal - The company has a manageable debt-to-equity ratio of 0.71, indicating low reliance on external financing.
growth - IDEXX's strong revenue growth and high return on equity attract growth-oriented investors.
moderate - The stock has shown some volatility, with a beta of approximately 1.2, reflecting its sensitivity to market movements.
